The Personalized Cancer Vaccines Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Personalized Cancer Vaccines Market?
The Personalized Cancer Vaccines Global Market Report 2025 indicated significant growth historically. The market size escalated from $242.29 billion in 2024 to $259.11 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Personalized Cancer Vaccines Industry?
The Personalized Cancer Vaccines Global Market Report 2025 projects that by 2029, the market size will reach $336.03 billion, growing at a compound annual growth rate (CAGR) of 6.7%.
Download Your Free Sample of the 2025 Personalized Cancer Vaccines Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Personalized Cancer Vaccines Market?
The key drivers in the personalized cancer vaccines market are:
• Advancements in precision medicine
• Increasing funding for cancer research
• Rise in cancer prevalence
• Improvements in genetic sequencing technologies
Global Market Segmentation: Identifying Major Personalized Cancer Vaccines Industry Segments
The personalized cancer vaccinesmarket covered in this report is segmented –
1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma
3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action
4) By Route Of Administration: Injectables, Other Routes Of Administration
5) By End Use: Hospitals, Clinic, Other End Users
Pre-order the 2025 Personalized Cancer Vaccines Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Personalized Cancer Vaccines Market?
The key trends in the personalized cancer vaccines market are:
• The integration of artificial intelligence in vaccine design is an emerging trend.
• There are advances in multi-antigen and neoantigen-based vaccines.
• The increased use of liquid biopsies for tumor monitoring is becoming more prevalent.
• Expansion of combination therapies and a greater focus on personalized treatment regimens are significant trends in the market.
Who Are the Top Competitors & Leading Players in the Personalized Cancer Vaccines Market?
Major companies in the personalized cancer vaccines market are:
• Merck & Co Inc.
• GlaxoSmithKline Plc
• NEC Corporation
• Moderna Inc.
• Catalent Inc.
• UCLA Health
• Genetech Inc.
• NHS England
• CureVac AG
• Personalis Inc.
• Achilles Therapeutics Plc
• Healio
• Moffitt Corporation
• BioPharma APAC
• Celebrity Angels
• EpiVax Therapeutics Inc.
• Evaxion Biotech AS
• Geneos Therapeutics Inc.
• IFL Sciense
• ISA Pharmaceuticals BV
• Oxford Global
• Kintara Therapeutics
• VAXIMM Gmbh
Regional Dominance: Which Area Leads the Global Personalized Cancer Vaccines Market?
North America was the largest region in the personalized cancer vaccines market in 2024
